These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35534635)

  • 1. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.
    Watanabe T; Yoshida T; Akizuki S; Yamanaka S; Nakao K; Fukuhara S; Asai K; Uozumi R; Bessho K
    J Bone Miner Metab; 2022 Jul; 40(4):657-662. PubMed ID: 35534635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw.
    Yamashita J; Sawa N; Sawa Y; Miyazono S
    Bone; 2021 Feb; 143():115611. PubMed ID: 32829042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.
    Watanabe T; Asai K; Fukuhara S; Uozumi R; Bessho K
    PLoS One; 2021; 16(1):e0244859. PubMed ID: 33395446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring indices of bone inflammatory activity of the jaw using SPECT bone scintigraphy: a study of ARONJ patients.
    Hata H; Kitao T; Sato J; Asaka T; Ohga N; Imamachi K; Hirata K; Shiga T; Yamazaki Y; Kitagawa Y
    Sci Rep; 2020 Jul; 10(1):11385. PubMed ID: 32647190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Periodontal Space Widening in Patients with Antiresorptive Drug-related Osteonecrosis of the Jaws (ARONJ) on Panoramic Radiographs.
    Assaf AT; Amberg V; Smeets R; Wikner J; Hanken H; Semmusch J; Ewald F; Rashad A; Friedrich RE
    Anticancer Res; 2018 Sep; 38(9):5305-5314. PubMed ID: 30194182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
    Fujieda Y; Doi M; Asaka T; Ota M; Hisada R; Ohnishi N; Kono M; Kameda H; Nakazawa D; Kato M; Amengual O; Takahata M; Yasuda S; Kitagawa Y; Atsumi T
    J Bone Miner Metab; 2020 Jul; 38(4):581-588. PubMed ID: 32076874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study.
    Sakai Y; Shindo T; Sato S; Takahashi A; Kunishima Y; Kato R; Itoh N; Okada M; Tachiki H; Taguchi K; Takayanagi A; Hotta H; Horita H; Matsukawa M; Matsuki M; Nishiyama K; Miyazaki A; Hashimoto K; Tanaka T; Masumori N
    J Bone Miner Metab; 2021 Jul; 39(4):661-667. PubMed ID: 33704573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study.
    Nashi M; Hirai T; Iwamoto T; Takenobu T
    J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of opacification in the nasal sinuses, rhinosinusitis, and antiresorptive agent-related osteonecrosis of the jaw.
    Matsumoto Y; Yokoi H; Ikeda T; Kawada M; Saito K
    Auris Nasus Larynx; 2020 Dec; 47(6):996-1002. PubMed ID: 32591168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ; Steybe D; Poxleitner P; Schmelzeisen R; Munzenmayer C; Fuellgraf H; Stricker A; Semper-Hogg W
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.
    ; Yoneda T; Hagino H; Sugimoto T; Ohta H; Takahashi S; Soen S; Taguchi A; Nagata T; Urade M; Shibahara T; Toyosawa S
    J Bone Miner Metab; 2017 Jan; 35(1):6-19. PubMed ID: 28035494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update MRONJ and perspectives of its treatment.
    Voss PJ; Poxleitner P; Schmelzeisen R; Stricker A; Semper-Hogg W
    J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):232-235. PubMed ID: 28697987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Osteomyelitis of the Mandibular Condyle Secondary to Bisphosphonate-related Osteonecrosis of the Jaw.
    Kato H; Uchibori M; Nakanishi Y; Kaneko A
    Tokai J Exp Clin Med; 2020 Sep; 45(3):126-130. PubMed ID: 32901900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Mandibular Nerve Block for Intractable Mandibular Pain Due to Antiresorptive Agent-Related Osteonecrosis of the Jaw: A Case Report.
    Fujimoto D; Obata N; Motoyama Y; Sato H; Takao Y; Mizobuchi S
    Kobe J Med Sci; 2020 Nov; 66(3):E90-E93. PubMed ID: 33431781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic imaging of drug-induced osteonecrosis of the jaw].
    Hingst V; Weber MA
    Radiologe; 2018 Oct; 58(10):935-948. PubMed ID: 30187078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis.
    Flores IL; dos Santos-Silva AR; Della Coletta R; Vargas PA; Lopes MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e264-8. PubMed ID: 24528798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current situation and future issues of antiresorptive agent-related osteonecrosis of the jaw].
    Takaoka K; Kishimoto H
    Nihon Yakurigaku Zasshi; 2019; 153(1):22-27. PubMed ID: 30643088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.